Search Results
Nov 04, 2025, 09:47 ET People Science and Phynova Launch Chloe LiveLab, A New Collaborative Ingredient-Brand Research Model to Generate Real-World Evidence
Research "Chloe LiveLab bridges the gap between RCTs and real-world consumers," said Belinda Tan, MD, PhD, Co-CEO and Co-Founder of People Science. "It turns research into a shared experience between suppliers, brands, and consumers. This is the next generation
More news about: People Science, Inc.
Nov 04, 2025, 09:15 ET State-of-the-Art "Drone Innovation Center" Set to Open on Full Sail University's Campus
entertainment media education and on-campus facilities to further incorporate the use, research, and study of drone technology," stated Haifa Maamar, PhD, Executive Director of Emerging Technologies at Full Sail University. This technology is used across numerous sectors that our students and graduates
More news about: Full Sail University
Nov 04, 2025, 09:02 ET Phenomix Sciences Expands Evidence for MyPhenome™ Test Predicting GLP-1 Response and Obesity Risk in Large, Diverse Populations
The studies, led by Mayo Clinic researcher and Phenomix co-founder Andres Acosta, MD, PhD, further validate the MyPhenome test's ability to predict patient response to GLP-1 therapies such as semaglutide and provide early insight
More news about: Phenomix Sciences
Nov 04, 2025, 09:00 ET Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"
https://www.heart.org/-/media/PHD-Files-2/Science-News/2/2024-Heart-and-Stroke-Stat-Update/2024-Statistics-At-A-Glance-final_2024.pdf
More news about: Abbott
Nov 04, 2025, 08:45 ET Chandigarh University Secures 1st Rank among Private Universities in India for 3rd Consecutive Year in QS Asia University Rankings 2026
Academic Reputation, Faculty Student Ratio, Outbound Exchange Students, Inbound Exchange Students, Papers per Faculty, Citations per Paper and Staff with PhD. Overall, Chandigarh University improved its score for most performance indicators. While Chandigarh University secured 1st
More news about: Chandigarh University
Nov 04, 2025, 08:32 ET iLeukon Receives FDA Clearance of IND Application for A Phase II Study of mRNA-based non-alpha IL-2 variant, ILKN421H, in Advanced Non-Small Cell Lung Cancer (NSCLC)
B-cell lymphomas. Media Contacts Brandon Nadres, PhD Product Development ManageriLeukon [email protected]
More news about: iLeukon Therapeutics
Nov 04, 2025, 08:30 ET MiDOG Expands Scientific Advisory Board with the Appointment of Dr. Curtis Huttenhower, Dr. Micah Kohles, and Dr. Krista A. Keller
Nov. 4, 2025 /PRNewswire/ -- MiDOG Animal Diagnostics is proud to announce the appointment of Dr. Curtis Huttenhower, PhD, Dr. Micah B. Kohles, DVM, MPA, and Dr. Krista A. Keller, DVM, Dipl. ACZM to its Board of Directors and Scientific Advisory Board. Together, these experts
More news about: MiDOG Animal Diagnostics
Nov 04, 2025, 08:30 ET Ensuring compliance with animal-free raw materials in CGT, Upcoming Webinar Hosted by Xtalks
Novo Nordisk Pharmatech A/S, Sara Bursomanno, PhD, Senior Global Product Manager; and Chantale Julien, Global Product Manager, for the live webinar on Thursday, November 20, 2025, at 10am EST (4pm CET/EU-Central).
More news about: Xtalks
Nov 04, 2025, 08:00 ET Bugcrowd Acquires Mayhem Security to Bring Human-Augmented AI Automation to Security Testing
Dr. Thanassis Avgerinos, two world-renowned cybersecurity innovators who each hold a PhD from Carnegie Mellon University. United by a vision to transform how organizations find and fix vulnerabilities, they've built a platform that blends
More news about: Bugcrowd
Nov 04, 2025, 07:00 ET Magnet Biomedicine Appoints Bharat Reddy, Ph.D., as Chief Business Officer
multimedia:https://www.prnewswire.com/news-releases/magnet-biomedicine-appoints-bharat-reddy-phd-as-chief-business-officer-302602874.html
More news about: Magnet Biomedicine
Nov 04, 2025, 07:00 ET Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
Samarendra Mohanty, PhD, President and Chief Scientific Officer of Nanoscope. "The absence of serious safety signals and strong participant retention underscore the potential
More news about: Nanoscope Therapeutics
Nov 04, 2025, 07:00 ET Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
Samarendra Mohanty, PhD, President and Chief Scientific Officer of Nanoscope. "The absence of serious safety signals and strong participant retention underscore the potential
More news about: Nanoscope Therapeutics
Nov 04, 2025, 06:45 ET SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
SOPHiA GENETICS, with revenue growth accelerating for a third consecutive quarter to 23% as new business continues to come online," said Jurgi Camblong, PhD., Chief Executive Officer and Co-founder. "We also demonstrated strong operating leverage as platform scalability and rigorous cost discipline resulted
More news about: SOPHiA GENETICS
Nov 04, 2025, 05:00 ET 'The Gaslit Brain' Exposes Global Leadership Crisis Fueled by Manipulation and Lies
from the Lies of Bullying, Gaslighting, and Institutional Complicity by award-winning Canadian educator and bestselling author Dr. Jennifer Fraser, PhD, is the first book to directly link gaslighting — infecting governments, bedrooms, workplaces and institutions worldwide — to measurable neurological
More news about: The Bullied Brain
Nov 04, 2025, 04:15 ET American Council of Learned Societies Launches 2026 Graduate Internships on the Spiritual Infrastructure of the Future Competition
generously by the Templeton Religion Trust. This program is intended to provide practical work opportunities in summer 2026 for talented, entrepreneurial PhD students in the humanities or social sciences whose dissertation topics relate to the study of religion, and to build institutional partnerships that
More news about: American Council of Learned Societies
Nov 03, 2025, 14:23 ET Vascarta Inc: Transdermal Curcumin (VAS-101 Drug Candidate) Interrupts the Neuroinflammatory Pathophysiological Cascade Associated with Acute Sickle Cell Crisis
[email protected]) Vascarta contact: Richard Prince, PhD – Chairman, Chief Executive Officer & PresidentEmail: [email protected]
More news about: Vascarta Inc
Nov 03, 2025, 13:31 ET Recordati Rare Diseases to Share New Data at the American Society of Hematology (ASH) Meeting
MD, PhD, MPH, Cleveland Clinic Poster number: 3001Title: Comprehensive analysis of subtype-specific outcomes and management in Castleman disease: a 20-year cohort studyPresenting author: Yoshito Nishimura, MD, PhD, MPH,
More news about: Recordati
Nov 03, 2025, 12:07 ET The Inner Circle acknowledges, Steven L. McCabe, PhD as a Pinnacle Lifetime Member
/PRNewswire/ -- Prominently featured in The Inner Circle, Steven L. McCabe, PhD is acknowledged as a Pinnacle Lifetime Member for his contributions in Leading Government Engineering Efforts. Steven L. McCabe, PhD, brings decades of expertise in engineering, particularly in earthquake
More news about: The Inner Circle
Nov 03, 2025, 12:07 ET The Inner Circle acknowledges, Shlomo Shinnar, MD, Ph.D. as a Pinnacle Lifetime Member
multimedia:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-shlomo-shinnar-md-phd-as-a-pinnacle-lifetime-member-302602767.html
More news about: The Inner Circle
Nov 03, 2025, 11:58 ET New Study Explores Placental Malperfusion's Impact on Fetal Health and Development in Congenital Heart Disease
Journal of the American College of Cardiology, the study, led by Rebecca Josowitz MD, PhD, also highlights that genetic changes in key pathways for placental and cardiac development may underlie PMP in CHD.
More news about: Children's Hospital of Philadelphia
Nov 03, 2025, 11:03 ET BrainXell Therapeutics Unveils Promising Preclinical Data Demonstrating Efficacy of BXT-110, an Autologous iPSC-Derived Neuronal Therapy, in Parkinson's Disease
Diego–based biotechnology company pioneering regenerative cell therapies for neurodegenerative diseases. Founded on the research of Dr. Su-Chun Zhang, MD, PhD, Advising CSO, the company's lead program, BXT-110, is advancing toward IND-enabling studies for Parkinson's disease. For
More news about: BrainXell, Inc.
Nov 03, 2025, 10:56 ET National Sleep Foundation to Host Drowsy Driving Prevention Expert Safety Panel
the stories about drowsy driving that can finally move the needle on prevention." The panel will be moderated by Mark Rosekind, PhD, a member of NSF's Board of Directors and former Administrator of the National Highway Traffic Safety Administration (NHTSA). Dr. Rosekind is also a
More news about: National Sleep Foundation
Nov 03, 2025, 08:39 ET $750,000 Michael F. Price Grant Awarded to Move Novel Cellular Therapy for Gastroesophageal Cancer into the Clinic
Foundation with support from the Torrey Coast Foundation has awarded a $750,000 Michael F. Price Memorial Grant to Eric Smith, MD, PhD, and Andrew Aguirre, MD, PhD, both of Dana-Farber Cancer Institute, and Sam Klempner, MD, Massachusetts General Hospital. The grant is for clinical translation of
More news about: DeGregorio Family Foundation
Nov 03, 2025, 08:30 ET Clinical Signals and Strategic Shifts: Insights That Shape Oncology Drug Development, Upcoming Webinar Hosted by Xtalks
Syneos Health, Dr. Jozsef Palatka, MD, Vice President, Medical Management; Dr. Rob Berg, MD, PhD, Vice President, Medical Management; and Marek Rombel, Managing Director, Commercial Advisory, for the live webinar on Thursday, November 20, 2025, at
More news about: Xtalks
Nov 03, 2025, 08:00 ET LPOXY Marks C. diff Awareness Month with First-in-Class Oral Preventive Preparing for Pivotal Trial
healthcare costs than all other CDC Urgent Threat Pathogens combined. For more information, please contact:Larry Sutton, MD, PhDCEO, LPOXY Therapeutics Inc.Phone: +1 (816) 200-0513Email: [email protected]
More news about: LPOXY Therapeutics, Inc